Hwan Jun Jae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hwan Jun Jae has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Jin Wook Chung
Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
11 shared publications - Saebeom Hur
Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea
10 shared publications - Hyo-Cheol Kim
Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
9 shared publications - Seung-Kee Min
Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
7 shared publications - Myungsu Lee
Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea
5 shared publications - Jin Woo Choi
Department of Radiology, Seoul National University Hospital, Seoul, Korea
4 shared publications
Latest Publications
- Open Access
- 20 May 2026
- Published by Elsevier in SSRN Electronic Journal
Synthesis of Fluorinated and Iodinated Cyanoacrylates and Their Application to Novel Liquid Embolic Composition
Liquid embolic agents are increasingly being adopted for endovascular embolization owing to their permanent occlusive effects, smooth injectability, and high vascular filling efficiency. Histoacryl®, one of the most widely used liquid embolic materials, presents limitations, including lack of intrinsic radiopacity and strong adhesion to microcatheters, which complicate procedural control and increase the risk of catheter entrapment.To overcome these challenges, a novel liquid embolic composition incorporating iodinated and fluorinated cyanoacrylates was developed. The iodinated component, 2-iodoethyl 2-cyanoacrylate (IECA), possesses a high iodine content (1,100 mg I/mL), exceeding that of Lipiodol® (480 mg I/mL), thereby enabling enhanced radiopacity for real-time fluoroscopic monitoring. The fluorinated monomer, 2,2,3,3,3-pentafluoropropyl 2-cyanoacrylate (PFPCA), exhibited a rapid polymerization rate (15.77 ± 1.96 μL/s), attributed to the strong electron-withdrawing effect of its pentafluoropropyl group, and effectively compensated for the slower polymerization of IECA even at low mixing ratios.In addition, the high hydrophobicity of PFPCA contributed to a significant reduction in microcatheter adhesion force (8.65 ± 0.79 N) compared to Histoacryl® (11.51 ± 0.45 N), thereby improving procedural safety and handling. In vivo embolization of rabbit renal arteries using the optimized composition of IECA, PFPCA, and ethyl oleate resulted in complete and stable occlusion of the target vessels.These results demonstrate that the iodinated and fluorinated cyanoacrylate-based liquid embolic formulation offers improved radiopacity, tunable polymerization kinetics, and reduced catheter adhesion, highlighting its potential for enhanced procedural control and minimized complication risks in endovascular embolization.
- 20 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSynthesis of Fluorinated and Iodinated Cyanoacrylates and Their Application to Novel Liquid Embolic Composition
Liquid embolic agents are increasingly being adopted for endovascular embolization owing to their permanent occlusive effects, smooth injectability, and high vascular filling efficiency. Histoacryl®, one of the most widely used liquid embolic materials, presents limitations, including lack of intrinsic radiopacity and strong adhesion to microcatheters, which complicate procedural control and increase the risk of catheter entrapment.To overcome these challenges, a novel liquid embolic composition incorporating iodinated and fluorinated cyanoacrylates was developed. The iodinated component, 2-iodoethyl 2-cyanoacrylate (IECA), possesses a high iodine content (1,100 mg I/mL), exceeding that of Lipiodol® (480 mg I/mL), thereby enabling enhanced radiopacity for real-time fluoroscopic monitoring. The fluorinated monomer, 2,2,3,3,3-pentafluoropropyl 2-cyanoacrylate (PFPCA), exhibited a rapid polymerization rate (15.77 ± 1.96 μL/s), attributed to the strong electron-withdrawing effect of its pentafluoropropyl group, and effectively compensated for the slower polymerization of IECA even at low mixing ratios.In addition, the high hydrophobicity of PFPCA contributed to a significant reduction in microcatheter adhesion force (8.65 ± 0.79 N) compared to Histoacryl® (11.51 ± 0.45 N), thereby improving procedural safety and handling. In vivo embolization of rabbit renal arteries using the optimized composition of IECA, PFPCA, and ethyl oleate resulted in complete and stable occlusion of the target vessels.These results demonstrate that the iodinated and fluorinated cyanoacrylate-based liquid embolic formulation offers improved radiopacity, tunable polymerization kinetics, and reduced catheter adhesion, highlighting its potential for enhanced procedural control and minimized complication risks in endovascular embolization.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250122
Embolization with N -Butyl Cyanoacrylate: Properties, Techniques, Applications, and Pitfalls
Glue embolization is a versatile and effective therapeutic procedure for a wide range of clinical indications, with its success dependent on comprehensive preprocedural planning, precise microcatheter positioning, and appropriate tailoring of the n-butyl cyanoacrylate–ethiodized oil mixture.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250122
Embolization with N -Butyl Cyanoacrylate: Properties, Techniques, Applications, and Pitfalls
Glue embolization is a versatile and effective therapeutic procedure for a wide range of clinical indications, with its success dependent on comprehensive preprocedural planning, precise microcatheter positioning, and appropriate tailoring of the n-butyl cyanoacrylate–ethiodized oil mixture.
- Open Access
- 25 March 2026
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 17 (6) , 1024-1033
Diabetic foot ulcer‐related amputation is associated with twofold increased risk of cardiovascular disease: A Korean National Health Information Database Study
Aims: To quantify the risk of cardiovascular disease (CVD) and all‐cause mortality associated with diabetic foot ulcer (DFU)‐related amputation using a large‐scale, nationally representative cohort. Materials and Methods: This longitudinal study included individuals with diabetes who underwent standardized national health checkups between 2009 and 2012, with follow‐up data obtained from the Korean National Health Insurance Service claims database. CVD was defined as an incident myocardial infarction or stroke occurring after the index health checkup. Cox proportional hazards models were used to estimate the hazard ratios (HRs) for CVD and mortality in individuals with DFU‐related amputation compared with those with diabetes but without amputation. Results: Among 1,229,689 individuals with diabetes, 1,486 (0.12%) had a DFU‐related amputation at baseline. The median follow‐up was 8.2 years in the non‐amputation group and 6.7 years in the DFU‐related amputation group. People with DFU‐related amputation had a significantly higher incidence rate of CVD compared with those without DFU‐related amputation (32.6 vs. 11.0 per 1000 person‐years) with a HR of 1.9 (95% CI 1.6–2.1). The HRs for myocardial infarction and stroke were 2.2 (95% CI 1.9–2.6) and 1.6 (95% CI 1.4–1.8), respectively. All‐cause mortality significantly increased in people with DFU‐related amputation compared with those without, with an HR of 2.1 (95% CI 1.9–2.3). Conclusions: In this nationwide population‐based cohort, DFU‐related amputation was associated with nearly a twofold increased risk of cardiovascular events and mortality. These findings underscore the importance of comprehensive cardiovascular risk assessment and management in patients with diabetic foot complications.
- 25 March 2026
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 17 (6) , 1024-1033
Open AccessDiabetic foot ulcer‐related amputation is associated with twofold increased risk of cardiovascular disease: A Korean National Health Information Database Study
Aims: To quantify the risk of cardiovascular disease (CVD) and all‐cause mortality associated with diabetic foot ulcer (DFU)‐related amputation using a large‐scale, nationally representative cohort. Materials and Methods: This longitudinal study included individuals with diabetes who underwent standardized national health checkups between 2009 and 2012, with follow‐up data obtained from the Korean National Health Insurance Service claims database. CVD was defined as an incident myocardial infarction or stroke occurring after the index health checkup. Cox proportional hazards models were used to estimate the hazard ratios (HRs) for CVD and mortality in individuals with DFU‐related amputation compared with those with diabetes but without amputation. Results: Among 1,229,689 individuals with diabetes, 1,486 (0.12%) had a DFU‐related amputation at baseline. The median follow‐up was 8.2 years in the non‐amputation group and 6.7 years in the DFU‐related amputation group. People with DFU‐related amputation had a significantly higher incidence rate of CVD compared with those without DFU‐related amputation (32.6 vs. 11.0 per 1000 person‐years) with a HR of 1.9 (95% CI 1.6–2.1). The HRs for myocardial infarction and stroke were 2.2 (95% CI 1.9–2.6) and 1.6 (95% CI 1.4–1.8), respectively. All‐cause mortality significantly increased in people with DFU‐related amputation compared with those without, with an HR of 2.1 (95% CI 1.9–2.3). Conclusions: In this nationwide population‐based cohort, DFU‐related amputation was associated with nearly a twofold increased risk of cardiovascular events and mortality. These findings underscore the importance of comprehensive cardiovascular risk assessment and management in patients with diabetic foot complications.
- 20 May 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (4) , 534-542
Long Term Outcomes of Open or Endovascular Treatment for Arterial Manifestations in Behçet Disease
- 20 May 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (4) , 534-542
Long Term Outcomes of Open or Endovascular Treatment for Arterial Manifestations in Behçet Disease
- 16 May 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (7) , 1133-1143.e1
Long-Term Outcomes of Angioplasty and Stent Placement for Portomesenteric Vein Obstruction following Hepatobiliary and Pancreatic Surgery
- 16 May 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (7) , 1133-1143.e1
Long-Term Outcomes of Angioplasty and Stent Placement for Portomesenteric Vein Obstruction following Hepatobiliary and Pancreatic Surgery
- Open Access
- 21 January 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (5) , 844-851.e1
Comparison of 2 Paclitaxel-Coated Balloons with Different Excipients for the Treatment of Femoropopliteal Artery Disease: A Randomized Prospective Trial
- 21 January 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (5) , 844-851.e1
Open AccessComparison of 2 Paclitaxel-Coated Balloons with Different Excipients for the Treatment of Femoropopliteal Artery Disease: A Randomized Prospective Trial
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (8) , e230140
Interventional Radiology for Bleeding Ectopic Varices: Individualized Approach Based on Vascular Anatomy
Ectopic varices are rare but potentially life-threatening conditions usually resulting from a combination of global portal hypertension and local occlusive components. As imaging, innovative devices, and interventional radiologic techniques evolve and are more widely adopted, interventional radiology is becoming essential in the management of ectopic varices. The interventional radiologist starts by diagnosing the underlying causes of portal hypertension and evaluating the afferent and efferent veins of ectopic varices with CT. If decompensated portal hypertension is causing ectopic varices, placement of a transjugular intrahepatic portosystemic shunt is considered the first-line treatment, although this treatment alone may not be effective in managing ectopic variceal bleeding because it may not sufficiently resolve focal mesenteric venous obstruction causing ectopic varices. Therefore, additional variceal embolization should be considered after placement of a transjugular intrahepatic portosystemic shunt. Retrograde transvenous obliteration can serve as a definitive treatment when the efferent vein connected to the systemic vein is accessible. Antegrade transvenous obliteration is a vital component of interventional radiologic management of ectopic varices because ectopic varices often exhibit complex anatomy and commonly lack catheterizable portosystemic shunts. Superficial veins of the portal venous system such as recanalized umbilical veins may provide safe access for antegrade transvenous obliteration. Given the absence of consensus and guidelines, a multidisciplinary team approach is essential for the individualized management of ectopic varices. Interventional radiologists must be knowledgeable about the anatomy and hemodynamic characteristics of ectopic varices based on CT images and be prepared to consider appropriate options for each specific situation. ©RSNA, 2024 Supplemental material is available for this article.
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (8) , e230140
Interventional Radiology for Bleeding Ectopic Varices: Individualized Approach Based on Vascular Anatomy
Ectopic varices are rare but potentially life-threatening conditions usually resulting from a combination of global portal hypertension and local occlusive components. As imaging, innovative devices, and interventional radiologic techniques evolve and are more widely adopted, interventional radiology is becoming essential in the management of ectopic varices. The interventional radiologist starts by diagnosing the underlying causes of portal hypertension and evaluating the afferent and efferent veins of ectopic varices with CT. If decompensated portal hypertension is causing ectopic varices, placement of a transjugular intrahepatic portosystemic shunt is considered the first-line treatment, although this treatment alone may not be effective in managing ectopic variceal bleeding because it may not sufficiently resolve focal mesenteric venous obstruction causing ectopic varices. Therefore, additional variceal embolization should be considered after placement of a transjugular intrahepatic portosystemic shunt. Retrograde transvenous obliteration can serve as a definitive treatment when the efferent vein connected to the systemic vein is accessible. Antegrade transvenous obliteration is a vital component of interventional radiologic management of ectopic varices because ectopic varices often exhibit complex anatomy and commonly lack catheterizable portosystemic shunts. Superficial veins of the portal venous system such as recanalized umbilical veins may provide safe access for antegrade transvenous obliteration. Given the absence of consensus and guidelines, a multidisciplinary team approach is essential for the individualized management of ectopic varices. Interventional radiologists must be knowledgeable about the anatomy and hemodynamic characteristics of ectopic varices based on CT images and be prepared to consider appropriate options for each specific situation. ©RSNA, 2024 Supplemental material is available for this article.
- Open Access
- 1 January 2024
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 85 (6) , 1044-1059
Study on the Necessity and Methodology for Enhancing Outpatient and Clinical Education in the Department of Radiology
조수범, et al. J Korean Soc Radiol. 2024 Nov;85(6):1044-1059. https://doi.org/10.3348/jksr.2023.0158
- 1 January 2024
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 85 (6) , 1044-1059
Open AccessStudy on the Necessity and Methodology for Enhancing Outpatient and Clinical Education in the Department of Radiology
조수범, et al. J Korean Soc Radiol. 2024 Nov;85(6):1044-1059. https://doi.org/10.3348/jksr.2023.0158
- Open Access
- 1 January 2024
- Published by XMLink in Korean Journal of Radiology
- Vol. 25 (6) , 565-574
Safety and Effectiveness of Passeo-18 Lux Drug-Coated Balloon Catheter in Infrainguinal Endovascular Revascularization in the Korean Population: A Multicenter Post-Market Surveillance Study
Choi TW, et al. Korean J Radiol. 2024 Jun;25(6):565-574. https://doi.org/10.3348/kjr.2024.0099
- 1 January 2024
- Published by XMLink in Korean Journal of Radiology
- Vol. 25 (6) , 565-574
Open AccessSafety and Effectiveness of Passeo-18 Lux Drug-Coated Balloon Catheter in Infrainguinal Endovascular Revascularization in the Korean Population: A Multicenter Post-Market Surveillance Study
Choi TW, et al. Korean J Radiol. 2024 Jun;25(6):565-574. https://doi.org/10.3348/kjr.2024.0099
- 1 July 2022
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 28 (4) , 359-363
Bronchial and non-bronchial systemic artery embolization with transradial access in patients with hemoptysis
PURPOSEWe aimed to determine the safety and feasibility of transradial access (TRA) in bronchial artery and non-bronchial systemic artery (NBSA) embolization in patients with non-massive hemoptysis.
- 1 July 2022
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 28 (4) , 359-363
Bronchial and non-bronchial systemic artery embolization with transradial access in patients with hemoptysis
PURPOSEWe aimed to determine the safety and feasibility of transradial access (TRA) in bronchial artery and non-bronchial systemic artery (NBSA) embolization in patients with non-massive hemoptysis.